EpiFibro – a nationwide databank for fibromyalgia syndrome – the initial analysis of 500 women  by Rezende, Marcelo C. et al.
www.reumatologia.com.br
REVISTA BRASILEIRA DE
REUMATOLOGIA
R E V  B R A S  R E U M A T O L .  2 0 1 3 ; 5 3 ( 5 ) : 3 8 2 – 3 8 7
* Corresponding author.
E-mail: marez@terra.com.br (M.C. Rezende)
0482-5004/$ - see front matter. © 2013 Elsevier Editora Ltda. All rights reserved.
Original article
EpiFibro – a nationwide databank for fi bromyalgia syndrome – 
the initial analysis of 500 women
Marcelo C. Rezendea,b, Eduardo S. Paivac, Milton Helfenstein Jr.d, Aline Ranzoline,f, 
José Eduardo Martinezg,*, Jose Roberto Provenzah, Carlos Eugênio Ribeiro Parolinii, 
Luiz Severiano Ribeiroj,k, Eduardo J. R. Souzal,m, Daniel P. Feldmand, 
Marcos Renato de Assisn, Roberto E. Heymannd
a Post-graduate Program in Rheumatology, Universidade do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
b Unit of Rheumatology, Santa Casa de Campo Grande, Campo Grande, MS, Brazil
c Discipline of Rheumatology, Department of Clinical Medicine, Universidade Federal do Paraná, Curitiba, PR, Brazil
d Discipline of Rheumatology, Escola Paulista de Medicina, Universidade Federal do Estado de São Paulo, São Paulo, SP, Brazil
e Post-graduation Program in Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
f Fibromyalgia Outpatient Clinic, Hospital das Clínicas de Pernambuco, Recife, PE, Brazil
g Department of Medicine, Pontifícia Universidade Católica de São Paulo, São Paulo, SP, Brazil
h Discipline of Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil
i Unit of Rheumatology, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil
j Rheumatology Residency Program, Hospital do Servidor Público de Minas Gerais, Belo Horizonte, MG, Brazil
k Doctoral Program in Public Health, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
l Fibromyalgia Outpatient Clinic, Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil
m Rheumatology Residency Program, Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil
n Marília School of Medicine, Marília, SP, Brazil
a r t i c l e  i n f o
Article history:
Received 13 June 2012
Accepted 7 March 2013
Keywords:
Fibromyalgia
Quality of life
Epidemiology
Database
a b s t r a c t
Introduction: Fibromyalgia syndrome (FS) is a common painful condition of the musculo-
skeletal system that is typically accompanied by several symptoms in other systems. In 
Brazil, the prevalence of FS is estimated at 2.5%. Here, we present the initial data from Epi-
Fibro, a nationwide databank of FS patients seen in public and private settings. 
Objective: The aims of this study were to assess how the diagnosis of FS was made, identify 
a set of clinical domains considered relevant by both clinicians and patients in cases of FS, 
analyse the impact of disease on patient quality of life, and compare the fi ndings among 
patients of public and private services. 
Methods: Based on the results of questionnaires, we analysed data corresponding to the fi rst 
500 women in the database. Questionnaires pertaining to demographic and clinical data 
and the Fibromyalgia Impact Questionnaire (FIQ), which was translated and validated for 
Brazilian patients, were completed by the clinicians and/or patients. 
Results: Preliminary analysis of the EpiFibro databank revealed that female FS patients in 
Brazil reported a high impact of disease, as measured by the FIQ, a high prevalence of as-
sociated symptoms, and a low degree of education (consistent with the public health care 
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EpiFibro – um banco de dados nacional sobre a síndrome da fi bromialgia – 
análise inicial de 500 mulheres
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r e s u m o
Introdução: A fi bromialgia (FM) é uma condição dolorosa do sistema musculoesquelético, ge-
ralmente acompanhada de vários sintomas em outros sistemas, com uma prevalência no 
Brasil estimada em 2,5%. Apresentamos os dados iniciais do EpiFibro, um banco de dados 
nacional de pacientes com FM atendidos em serviços públicos e privados. 
Objetivo: Avaliar como é feito o diagnóstico da doença, identifi car um conjunto de domínios 
clínicos considerados relevantes por médicos e por pacientes com FM, analisar o impacto 
da doença na qualidade de vida dos pacientes e comparar os achados entre pacientes de 
serviços público e privado.
Métodos: Foram analisadas as respostas das primeiras 500 mulheres nesse banco de da-
dos. Esse banco de dados foi baseado em um questionário contendo dados demográfi cos e 
clínicos. O Fibromyalgia Impact Questionnaire (FIQ), traduzido e validado para o Brasil, foi 
preenchido pelos médicos e/ou pacientes. 
Resultados: Uma análise preliminar do banco de dados EpiFibro revelou que as pacientes 
com FM no Brasil têm um alto impacto da doença avaliada pelo FIQ, uma alta prevalência 
de sintomas associados, um baixo grau de educação (um achado que pode ser explicado 
pelo fato de a saúde pública no Brasil ser usada principalmente por aqueles desfavorecidos 
socialmente) e a maioria percebe a sua dor como sendo difusa a partir do início da doença.
Conclusão: Depressão e ansiedade são percebidas como as principais causas dos sintomas 
da FM, mas uma quantidade signifi cativa considera o esforço no trabalho como o primeiro 
gatilho. Há um atraso de poucos anos em busca de ajuda médica e para chegar ao reuma-
tologista.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
in Brazil used mainly by the underserved). In addition, most patients perceived their pain 
as diffuse from the onset of disease. 
Conclusion: Depression and anxiety were seen as the main triggers of FM symptoms, but a 
signifi cant proportion of the subjects perceived work strain as the initial trigger. We also ob-
served a delay of a few years in seeking medical help and examination by a rheumatologist.
© 2013 Elsevier Editora Ltda. All rights reserved.
Introduction
Fibromyalgia syndrome (FS) is a painful condition that is 
highly prevalent in the global population. In Brazil, the 
prevalence of FS is estimated at 2.5%.1 FS is characterised by 
chronic musculoskeletal pain and is usually accompanied by 
various other symptoms unrelated to the locomotor system. 
The manifestations of this disease depend on social, psycho-
logical, and cultural factors, among others, which makes the 
clinical expression of this disease highly varied and requires 
the use of different therapeutic approaches. Moreover, there 
is critical need for epidemiological studies on FS in Brazil. 
The EpiFibro (Estudo Epidemiológico da Fibromialgia no Brasil 
[Epidemiological Study of Fibromyalgia in Brazil]) was created 
to analyse the epidemiology of FS and its comorbidities across 
Brazil. Using suitable on-line questionnaire, this database 
sought to provide better information for the assessment of 
diagnosis, treatment and impact of this disorder in the Brazil-
ian society.
The objective of the current project was to assess how the 
diagnosis of FS is carried out, including the time required to 
perform a diagnosis; identify a set of potential clinical do-
mains in FS cases, which were considered relevant by doctors 
and patients; and analyse the impact of the disease on the 
quality of life of patients. We also sought to identify the most 
commonly used treatments and assess whether there were 
differences among private and public health care systems. 
With this information, we hope to shorten the time required 
for diagnosis, improve FS diagnosis, treat patients earlier, pro-
vide more adequate treatment, and improve the quality of life 
of patients.
Materials and methods
The questionnaire was divided into 3 parts: 1) the registra-
tion form for the physician, which was completed only once 
using registration data obtained by the assistant physician, 
pertaining to how the diagnosis of FS was performed as well 
as the physician’s opinion regarding the occupational aspect 
of FS; 2) the registration form for the patient, containing an 
initial page presenting data on diagnosis and treatment that 
was completed by the physician, with the remainder to be 
self-completed pertaining to registration and epidemiological 
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data and the details of the patient’s symptoms; and 3) the pa-
tient follow-up sheet, which was completed during the fi rst 3 
consultations following the initial assessment; this form was 
available online and was completed jointly by the physician 
and the patient.
All patients completed an informed consent form, and the 
project was approved by the Research Ethics Committee (Co-
mitê de Ética em Pesquisa – CEP) of the Hospital das Clínicas 
of the Universidade Federal do Paraná.
A standardised questionnaire was also used in the inves-
tigation, which was completed via the internet by physicians 
who provided care to FS patients, both in the public and pri-
vate sectors. All information was entered online in the re-
spective databases for tabulation. Subsequently, these data 
were scanned on the website (www.renaprom.com.br) and 
then encrypted for access only with permission of the Brazil-
ian Society of Rheumatology (Sociedade Brasileira de Reuma-
tologia – SBR), which was responsible for the reliability of the 
project.
Based on the results of these questionnaires, data from the 
fi rst 500 women were analysed. All patients were assessed by 
rheumatologists, and all met the FS criteria of the American 
College for Rheumatology (ACR) 1990.2 A questionnaire con-
taining demographic and clinical data and the Fibromyalgia 
Impact Questionnaire (FIQ), which was translated and vali-
dated for Brazilian patients, were completed by the respective 
physicians.
The results of quantitative variables were expressed as the 
mean, median, minimum value, maximum value, and stan-
dard deviation. The results of qualitative variables were ex-
pressed as frequencies and percentages. For comparison of 
groups defi ned by the health care setting (public or private) 
with quantitative variables, Student’s t-test for independent 
samples or the nonparametric Mann-Whitney test were used 
as appropriate. Comparisons of the qualitative variables were 
performed using the Chi-square or Fisher’s exact test. P val-
ues < 0.05 were considered statistically signifi cant. Data were 
analysed using the Statistica v.8.0 computer software.
Results
Patients treated in the public setting comprised 70% of the 
sample. The mean age was 50.16 years (± 10.85), with a mini-
mum age of 17 years and maximum of 89 years (median of 51 
years). The majority (59.4%) of patients were married (Fig. 1), 
and approximately one-third had not completed elementary 
education (Fig. 2). Regarding the occupational activity of the 
patients, 31% were employed, 21% were housewives, and 34% 
were unemployed or retired (Fig. 3). The household income for 
the vast majority of the families of the patients (73.4%) was 
less than R$ 2,000.00 per month (Fig. 4).
Regarding the patients’ perception of what triggered their 
FS symptoms, 39.4% considered certain working conditions 
and 51% consider anxiety or depression to be the trigger. 
Some of the patients believed their symptoms had resulted 
from more than a single cause (Fig. 5).
Most of the patients stated that their pain had started as 
diffuse (70.2%). Approximately 25% of the patients waited 
more than 3 years to consult a doctor, and 42% waited more 
Fig. 1 – Marital status
Fig. 2 – Educational level.
Fig. 3 – Occupational activity.
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Fig. 4 – Percentage of family income.
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than 3 years to consult a rheumatologist. Most patients fi rst 
consulted with a general practitioner or an orthopaedist to 
evaluate their complaints.
Approximately 55% of patients were diagnosed at the 
time they entered the databank, and approximately 43% 
were follow-up patients; we did not obtain this type of infor-
mation for approximately 2% of patients. Among the 277 pa-
tients who were diagnosed when they entered the databank, 
approximately three-quarters (74.37%) reported pain for 
more than 3 years, 70% had visited more than 3 physicians 
before the diagnosis was made, and 44% of patients had only 
consulted a rheumatologist after a period of 3 years from the 
fi rst consultation with another medical professional.
The main symptoms associated with FS included sleep 
disorders (86%), fatigue (84.6%), anxiety (77.2%), pares-
thesia (75%), and headache (72.6). The average number of 
symptoms associated with chronic musculoskeletal pain in 
these patients was 8.6 ± 3.2 (0-15). These patients had an 
average of 13.74 tender points. The average FIQ score was 
60.82 (with a maximum value possible of 100), which was 
considered to indicate a signifi cant impact of FS on the pa-
tients’ quality of life.
Table 1 shows that the patients from the public sector re-
ported lower levels of education compared to private-sector 
patients, who also reported more diffuse pain in the begin-
ning of the disease (77.71% vs. 55.49% in private patients). 
However, there was no difference between these groups re-
garding the FIQ scores (60.65 vs. 62.67, respectively).
Discussion 
Public health care patients represented the majority of this 
sample. In addition, a substantial proportion of the patients 
analysed did not complete elementary education, indicating 
that they possessed a low educational level, which put them 
at a disadvantage in the labour market and in other life situ-
ations. More than half of the patients were not employed and 
were considered housewives, retired or unemployed. More-
over, approximately three-quarters of the patients reported 
a low family income, and psychosocial factors such as these 
have been shown to interfere with FS symptoms.3
Many patients cited working conditions and/or psycholog-
ical disorders, particularly depression and anxiety, as factors 
responsible for the onset of their disease symptoms. However, 
there is no scientifi c evidence to suggest that FS has an occu-
pational origin or that this chronic pain syndrome is caused 
by depression, anxiety, or other psychogenic illness. Although 
a few articles published in the 1990´s related trauma in the 
workplace to the onset of FS,4-6 there is insuffi cient data in the 
literature to characterise such causality. Moreover, previous 
studies have been conducted with small patient samples or 
were documented as isolated case reports.7,8
It remains unclear whether FS symptoms worsen when 
patients are subjected to strict criteria of productivity and 
pressure in the workplace. However, the biomechanical lim-
its of these patients have yet to be established, and well as 
the impact of any reduction, modifi cation, or elimination of 
specifi c tasks they perform. Systematic reviews suggest that 
there is currently no work-related intervention strategy that 
can be considered effective for the occupational aspects of 
disease in these patients.9,10
Importantly, as with any other chronic pain syndrome, mo-
tivation at work can be infl uenced by social and psychological 
factors. For example, it is known that patients with chronic 
pain tend to experience worse symptoms when they are also 
affected by associated psychological disorders. A study in Bra-
zil found that 30% of FS patients exhibited severe depression 
and 34% moderate depression, and this study further showed 
that 70% of patients demonstrated signifi cant anxiety and 
88% showed a high state of anxiety.11 Data from the present 
study are in full agreement with the fi ndings of other stud-
ies, which have shown that FS patients have a signifi cantly 
higher prevalence of depressive disorders and anxiety when 
compared to controls. In addition to their high prevalence, 
psychiatric disorders and FS also exhibit sociodemographic 
and clinical similarities.12 In particular, a heterogeneous se-
ries of disorders, mainly involving the autonomic, neuroendo-
crine, and neuropsychiatric systems, can be observed in these 
patients, and the chronic state of psychophysical pain in FS 
adversely affects the quality of life, performance and mood 
state of patients. Therefore, many factors indicate a common 
pathophysiology between FS and various types of psychiat-
ric illnesses, including changes in neurotransmitter systems, 
which may represent a common underlying mechanism.13,14 
Furthermore, many FS cases may benefi t from the help of an 
expert in the fi eld of mental disorders. However, it should be 
noted that there is no scientifi c literature to defi nitively show 
that FS is caused by a psychiatric disorder.15
Most patients in the present study reported that their con-
dition began with diffuse pain, yet a substantial portion of 
patients took more than 3 three years to seek medical help 
and consult a rheumatologist. These fi ndings indicate con-
siderable delayed diagnosis and hence delayed onset of treat-
ment. It was also observed that a signifi cant number of pa-
Table 1 – Public and private patients.
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Mean FIQ 60.65% 62.67% ns
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Fig. 5 – Patients’ opinion regarding triggering factor.
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tients consulted more than three doctors before receiving a 
diagnosis, which likely resulted in wasted time, unnecessary 
direct and indirect costs, and increased levels of stress. These 
data show that patients need better guidance and better ac-
cess to specialists.
This study also found that the main symptoms associated 
with FS included sleep disorders, fatigue, anxiety, paresthesia, 
and headaches in over 70% of patients. The average number 
of associated symptoms (approximately nine) was another 
important fi nding, and this high prevalence of associated 
symptoms is similar to that reported in another study con-
ducted in Brazil, which observed, in decreasing order of prev-
alence, stiffness, sleep disorder, fatigue paresthesia, impaired 
memory, headache, palpitation, dizziness, bloating, and chest 
pain in at least 70% of FS patients examined.16 These fi ndings 
refl ect the major symptoms of this syndrome and the care 
that must be taken in diagnostic assessment, particularly the 
use of good propaedeutics and proper knowledge of the wide 
range of differential diagnosis.17,18
In addition to the large number of reported symptoms, the 
elevated tender point and FIQ values that were obtained in 
this study refl ect the signifi cant impact of this disease on the 
quality of life of patients. These data further indicate that the 
therapeutic approach should be quickly established and that 
treatment should be comprehensive and involve multiple 
strategies (both with and without medication).19,20
Although public health care patients demonstrated lower 
levels of education and reported more diffuse pain since the 
onset of symptoms compared to private care patients, they 
did not differ in FIQ values. This fi nding suggested that the 
impact of the disease was equally signifi cant in both patient 
groups, a result that differs from that observed previously in 
the international literature. 
Conclusions
This pioneering program entitled EpiFibro was created with 
the goal of improving the quality of care for patients with FS.
FS is a chronic pain disorder characterised by multiple 
symptoms, particularly diffuse pain in the musculoskeletal 
system. This syndrome has a negative impact on many do-
mains of the patients’ lives, including performance, motiva-
tion, and quality of life. FS also has fi nancial consequences for 
patients and the health care system due to repeated spending 
on diagnostic assessment and treatment.
This preliminary analysis of the EpiFibro databank re-
vealed that many women with FS in Brazil have a low educa-
tional level, are poorly informed about their disease, and are 
slow to seek medical help and the advice of a rheumatologist. 
In fact, we found that diagnosis could take several years to 
be performed. Our fi ndings also revealed that these patients 
have a high prevalence of associated symptoms, experience a 
signifi cant negative impact on their quality of life, and suffer 
from a signifi cant delay in initiating treatment.
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